November 22, 2024- In response to the increasing shortage of oncology nurses and the high turnover rates in the profession, The US Oncology Network (The Network), a leading oncology organization supported by McKesson dedicated to advancing local cancer care and better patient outcomes, has developed an innovative program to support the professional development and … [Read more...]

November 22, 2024- Henry Schein, Inc. announced that the Company will present at the following investor conferences in December: Henry Schein’s presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts. Replays will be available on the Henry Schein website following the presentations. Continue Reading … [Read more...]

November 22, 2024- SMI® celebrated its 20th anniversary along with 27 inaugural member organizations at the SMI Fall Forum in Austin, TX. These members were honored in front of over 250 SMI members and invited guests. SMI members meet twice annually at Forums to discuss industry challenges, share learnings and best practices, and work side-by-side to create solutions and … [Read more...]

November 22, 2024-  A first of its kind Human Papillomavirus (HPV) self-collection screening pilot program aimed at improving cervical cancer screening in underserved communities has officially launched in Texas. HPV is the cause of virtually all cervical cancers. The study is being conducted at Su Clinica, a Federally Qualified Health Center (FQHC) with locations … [Read more...]

November 21, 2024- Insured rates in the U.S. are near-record highs, but 1 in 4 Americans are underinsured, according to the Commonwealth Fund's Biennial Health Insurance Survey. The biennial survey polls U.S. adults age 19 and older on their insurance status, according to Becker's. The 2024 survey includes responses from more than 6,000 individuals aged 19-64. … [Read more...]

November 21, 2024- Pfizer Inc. announced that after a comprehensive internal and external selection process, the company is appointing Chris Boshoff, M.D., PhD, as Chief Scientific Officer and President, Research & Development effective January 1, 2025. Dr. Boshoff, who most recently served as Chief Oncology Officer and Executive Vice President, will succeed Dr. Mikael … [Read more...]

November 21, 2024- QuidelOrtho Corporation announced the pricing of the previously announced underwritten secondary offering (the “Offering”) by Carlyle Partners VI Cayman Holdings, L.P. (the “Selling Stockholder”) of 8,260,183 shares of the Company’s common stock (“Common Stock”). The Selling Stockholder will receive all of the proceeds from the Offering. The Company is not … [Read more...]

November 21, 2024- Diabetes affects approximately 40 million Americans, according to the CDC’s National Diabetes Statistics Report – but not all are impacted equally. As part of National Diabetes Awareness Month, Cardinal Health is shining a spotlight on the Hispanic American population as one of the largest and fastest-growing minority population in the United States – and one … [Read more...]

November 21, 2024- On November 21, Baxter announced that the company has released the first product, 1-liter IV solutions, that has been manufactured since Hurricane Helene. Baxter stated in a press release that this is ahead of the company's original expectations, and made possible by the dedication and resilience of the North Cove and broader Baxter teams, working in … [Read more...]

November 20, 2024- Cardinal Health announced the U.S. launch of its Kendall SCD SmartFlow™ Compression System, the next generation of the Kendall™ Compression Series offering an enhanced clinician and patient experience. Featuring clinically proven technology that delivers customized, intermittent pneumatic compression (IPC) to increase blood flow in at-risk patients, the … [Read more...]